| The Lymphochip: Barriers to Developing a Diagnostic Test | Dr. Louis Staudt |
| Discussion of potential barriers to development of new, comprehensive molecular technologies | |
| Discussion of reports from subcommittees Publication guidelines Marker development guidelines Predictive markers development guidelines |
Dr. Lisa McShane Dr. Liz Hammond Dr. Joe Gray |
| Presentations of “promising markers” - application of guidelines Microsatellite instability Proliferation markers in breast cancer Discussion of possible demonstration project |
Dr. Barbara Conley Dr. Sheila Taube Dr. Soon Paik |
| Infrastructure issues - tissue micro-arrays and other tissue reference sets; ligand generation facility; device optimization issues |
